Key result
In adults with moderate-to-severe CKD, each 15 ml/min/1.73 m² lower eGFR was associated with declines in physical function equivalent to approximately 3-5 additional years of aging.
Why the study?
Individuals with CKD experience substantial impairments in physical function linked to disability and mortality, but the trajectory of functional decline across stages of CKD remains poorly characterized.
Cohort (n=3,955)
Yes
In adults with moderate to severe CKD, lower eGFR is independently associated with accelerated, progressive decline in objective physical function equivalent to 3-5 years of additional aging per 15 ml/min/1.73m2 decrease.
Introduction: Individuals with chronic kidney disease (CKD) experience substantial impairments in physical function that are linked to disability and mortality, yet the trajectory of functional decline across stages of CKD remains poorly characterized.We examined baseline levels and longitudinal changes in objective physical function in a large prospective CKD cohort.Methods: At 2-3 year intervals, the Chronic Renal Insufficiency Cohort (CRIC) Study measured grip strength (kilograms) and the Short Physical Performance Battery (SPPB; range: 0-12), including gait speed (meters/second), 5-repetition chair stand time (seconds), and balance.Linear mixed-effects models estimated annual changes in physical function adjusted for age, sex, estimated glomerular filtration rate (eGFR), body mass index, diabetes, cardiovascular disease, education, hemoglobin, physical activity, and depressive symptoms.Baseline physical function was compared with age-matched population reference values and categorized using published impairment thresholds.Results: Among 3,955 participants (mean age 62 10 years, mean eGFR 47 20 ml/min/1.73m 2 , 43% female), baseline impairment was common: 33% gait speed, 70% chair stands, 43% grip strength, and 50% SPPB.Compared with normative values, physical function was up to 75% worse depending on age and test.Over a median follow up of 8.5 years, older age and lower eGFR were associated with steeper declines across measures.After full adjustment, each 15 ml/min/1.73m lower eGFR was associated with declines equivalent to approximately 3-5 additional years of aging.Conclusion: Physical function impairment is common and progressive in moderate-to-severe CKD, with kidney dysfunction contributing substantially to functional decline beyond chronological aging.Although per-unit changes are modest, their cumulative impact over time may be clinical meaningful.These findings support evaluation of objective physical function measures in CKD and the development and testing of interventions to preserve function and independence.
No takes yet. Share an insight, caveat, or question.
Schrauben et al. (2026) conducted a cohort in Moderate to Severe Chronic Kidney Disease (n=3,955). Lower eGFR (per 15 ml/min/1.73m2) vs. Higher eGFR was evaluated on Annual change in SPPB performance (β -0.02 points/year). In adults with moderate-to-severe CKD, each 15 ml/min/1.73 m² lower eGFR was associated with declines in physical function equivalent to approximately 3-5 additional years of aging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: